Efficacy of immune checkpoint inhibitors in patients with brain metastasis from NSCLC, RCC, and melanoma. Phase I/II study of low-dose cyclophosphamide, tumor-associated peptide antigen-pulsed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback